Biofrontera Inc. (NASDAQ:BFRI) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRI) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 97,800 shares, a growth of 19.7% from the February 28th total of 81,700 shares. Based on an average daily volume of 384,300 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.3% of the company’s shares are short sold.

Biofrontera Trading Down 0.1 %

Shares of NASDAQ:BFRI opened at $0.80 on Wednesday. The company has a market capitalization of $7.09 million, a price-to-earnings ratio of -0.35 and a beta of 0.30. Biofrontera has a 12-month low of $0.65 and a 12-month high of $2.43. The business has a 50-day moving average price of $1.01 and a 200 day moving average price of $1.01.

Institutional Investors Weigh In On Biofrontera

A number of institutional investors have recently made changes to their positions in BFRI. Virtu Financial LLC purchased a new position in shares of Biofrontera during the 4th quarter worth approximately $48,000. AIGH Capital Management LLC boosted its position in shares of Biofrontera by 61.8% during the fourth quarter. AIGH Capital Management LLC now owns 811,097 shares of the company’s stock worth $884,000 after buying an additional 309,663 shares during the period. Finally, Rosalind Advisors Inc. grew its stake in shares of Biofrontera by 63.9% in the fourth quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock valued at $885,000 after buying an additional 316,428 shares in the last quarter. 10.08% of the stock is currently owned by institutional investors and hedge funds.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.